Biosig commences clinical trial enrollment for pure ep system

Biosig technologies, inc. announced that the company commenced its first clinical trial for its pure ep system. texas cardiac arrhythmia research foundation (tcarf) in austin, texas, is the first institution to conduct patient cases under the clinical trial titled, novel cardiac signal processing system for electrophysiology procedures (pure ep 2.0 study)". eight patient enrollments were achieved during the first week of the trial. the data collected during the trial is planned to be submitted for abstract consideration at leading industry events throughout 2020, including the heart rhythm scientific sessions in may 2020.
BSGM Ratings Summary
BSGM Quant Ranking